MedPath

石家庄市华新药业有限责任公司

Ownership
-
Established
1999-10-17
Employees
-
Market Cap
-
Website
hxpharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

68

NMPA:68

Drug Approvals

Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution

Product Name
氨溴特罗口服溶液
Approval Number
国药准字H20234252
Approval Date
Jan 19, 2024
NMPA

Trimetazidine Hydrochloride Sustained-release Tablets

Product Name
盐酸曲美他嗪缓释片
Approval Number
国药准字H20223951
Approval Date
May 22, 2023
NMPA

Indapamide Tablets

Product Name
吲达帕胺片
Approval Number
国药准字H20084485
Approval Date
May 16, 2023
NMPA

Roxithromycin Capsules

Product Name
罗红霉素胶囊
Approval Number
国药准字H20083375
Approval Date
Dec 30, 2022
NMPA

Mycophenolate mofetil Dispersible Tablets

Product Name
吗替麦考酚酯分散片
Approval Number
国药准字H20080281
Approval Date
Dec 30, 2022
NMPA

Vitamin E Nicotinicate Capules

Product Name
维生素E烟酸酯胶囊
Approval Number
国药准字H20083444
Approval Date
Dec 30, 2022
NMPA

Mycophenolate mofetil Dispersible Tablets

Product Name
吗替麦考酚酯分散片
Approval Number
国药准字H20080280
Approval Date
Dec 30, 2022
NMPA

Valsartan and Amlodipine Tablets(Ⅰ)

Product Name
缬沙坦氨氯地平片(Ⅰ)
Approval Number
国药准字H20213994
Approval Date
Dec 31, 2021
NMPA

Azithromycin for Suspension

Product Name
阿奇霉素干混悬剂
Approval Number
国药准字H20073728
Approval Date
Dec 13, 2021
NMPA

Ampicillin and Probenecid Capsules

Product Name
氨苄西林丙磺舒胶囊
Approval Number
国药准字H20073822
Approval Date
Dec 13, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.